GW&K Investment Management LLC Purchases 28,203 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

GW&K Investment Management LLC increased its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 8.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 344,390 shares of the company's stock after purchasing an additional 28,203 shares during the quarter. GW&K Investment Management LLC owned approximately 2.27% of U.S. Physical Therapy worth $24,920,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in USPH. Point72 Asia Singapore Pte. Ltd. bought a new position in U.S. Physical Therapy during the fourth quarter valued at approximately $39,000. Fifth Third Bancorp boosted its stake in U.S. Physical Therapy by 34.6% during the first quarter. Fifth Third Bancorp now owns 1,030 shares of the company's stock valued at $75,000 after buying an additional 265 shares during the last quarter. Lazard Asset Management LLC bought a new position in U.S. Physical Therapy during the fourth quarter valued at approximately $84,000. Aquatic Capital Management LLC boosted its stake in U.S. Physical Therapy by 18.0% during the fourth quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock valued at $115,000 after buying an additional 198 shares during the last quarter. Finally, First Horizon Advisors Inc. boosted its stake in U.S. Physical Therapy by 35.0% during the first quarter. First Horizon Advisors Inc. now owns 1,929 shares of the company's stock valued at $140,000 after buying an additional 500 shares during the last quarter.

U.S. Physical Therapy Trading Down 1.0%

Shares of NYSE USPH traded down $0.77 during midday trading on Thursday, hitting $74.76. The company's stock had a trading volume of 103,345 shares, compared to its average volume of 137,296. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.32. The business's 50 day moving average is $76.71 and its two-hundred day moving average is $78.26. U.S. Physical Therapy, Inc. has a 12-month low of $62.77 and a 12-month high of $101.19. The firm has a market cap of $1.14 billion, a P/E ratio of 34.28, a price-to-earnings-growth ratio of 3.64 and a beta of 1.44.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.02. U.S. Physical Therapy had a return on equity of 7.89% and a net margin of 4.57%. The firm had revenue of $183.79 million for the quarter, compared to the consensus estimate of $176.78 million. During the same period in the prior year, the business posted $0.51 earnings per share. The company's revenue for the quarter was up 18.0% on a year-over-year basis. As a group, equities research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, June 13th. Stockholders of record on Friday, May 23rd were issued a $0.45 dividend. The ex-dividend date was Friday, May 23rd. This represents a $1.80 annualized dividend and a dividend yield of 2.41%. U.S. Physical Therapy's payout ratio is 82.57%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on USPH shares. JMP Securities reissued a "market outperform" rating and set a $113.00 price target on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Wall Street Zen raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $98.00 price objective on shares of U.S. Physical Therapy in a research note on Tuesday, July 1st. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $109.00.

Insider Buying and Selling at U.S. Physical Therapy

In other news, Director Nancy Ham sold 400 shares of the stock in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $78.01, for a total value of $31,204.00. Following the sale, the director directly owned 2,594 shares in the company, valued at approximately $202,357.94. This represents a 13.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 2.00% of the company's stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.